Literature DB >> 21784926

Proteolytic cleavage inactivates the Staphylococcus aureus lipoteichoic acid synthase.

Mirka E Wörmann1, Nathalie T Reichmann, Cheryl L Malone, Alexander R Horswill, Angelika Gründling.   

Abstract

Lipoteichoic acid (LTA) is a crucial cell envelope component in Gram-positive bacteria. In Staphylococcus aureus, the polyglycerolphosphate LTA molecule is synthesized by LtaS, a membrane-embedded enzyme with five N-terminal transmembrane helices (5TM domain) that are connected via a linker region to the C-terminal extracellular enzymatic domain (eLtaS). The LtaS enzyme is processed during bacterial growth, and the eLtaS domain is released from the bacterial membrane. Here we provide experimental evidence that the proteolytic cleavage following residues 215Ala-Leu-Ala217 is performed by the essential S. aureus signal peptidase SpsB, as depletion of spsB results in reduced LtaS processing. In addition, the introduction of a proline residue at the +1 position with respect to the cleavage site, a substitution known to inhibit signal peptidase-dependent cleavage, abolished LtaS processing at this site. It was further shown that the 5TM domain is crucial for enzyme function. The observation that the construction of hybrid proteins between two functional LtaS-type enzymes resulted in the production of proteins unable to synthesize LTA suggests that specific interactions between the 5TM and eLtaS domains are required for function. No enzyme activity was detected upon expression of the 5TM and eLtaS domains as separate fragments, indicating that the two domains cannot assemble postsynthesis to form a functional enzyme. Taken together, our data suggest that only the full-length LtaS enzyme is active in the LTA synthesis pathway and that the proteolytic cleavage step is used as a mechanism to irreversibly inactivate the enzyme.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21784926      PMCID: PMC3187375          DOI: 10.1128/JB.00369-11

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  46 in total

1.  Lipoteichoic acid and lipoteichoic acid carrier in Staphylococcus aureus H.

Authors:  M Duckworth; A R Archibald; J Baddiley
Journal:  FEBS Lett       Date:  1975-05-01       Impact factor: 4.124

2.  Extracellular proteins of Staphylococcus aureus and the role of SarA and sigma B.

Authors:  A K Ziebandt; H Weber; J Rudolph; R Schmid; D Höper; S Engelmann; M Hecker
Journal:  Proteomics       Date:  2001-04       Impact factor: 3.984

Review 3.  Lipoteichoic acid and lipids in the membrane of Staphylococcus aureus.

Authors:  W Fischer
Journal:  Med Microbiol Immunol       Date:  1994-05       Impact factor: 3.402

4.  The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage.

Authors:  B N Kreiswirth; S Löfdahl; M J Betley; M O'Reilly; P M Schlievert; M S Bergdoll; R P Novick
Journal:  Nature       Date:  1983 Oct 20-26       Impact factor: 49.962

5.  A proteomic view on genome-based signal peptide predictions.

Authors:  H Antelmann; H Tjalsma; B Voigt; S Ohlmeier; S Bron; J M van Dijl; M Hecker
Journal:  Genome Res       Date:  2001-09       Impact factor: 9.043

6.  Requirement of the Listeria monocytogenes broad-range phospholipase PC-PLC during infection of human epithelial cells.

Authors:  Angelika Gründling; Mark D Gonzalez; Darren E Higgins
Journal:  J Bacteriol       Date:  2003-11       Impact factor: 3.490

7.  Synthesis of glycerol phosphate lipoteichoic acid in Staphylococcus aureus.

Authors:  Angelika Gründling; Olaf Schneewind
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-03       Impact factor: 11.205

8.  Biosynthesis of membrane-derived oligosaccharides: characterization of mdoB mutants defective in phosphoglycerol transferase I activity.

Authors:  B J Jackson; J P Bohin; E P Kennedy
Journal:  J Bacteriol       Date:  1984-12       Impact factor: 3.490

9.  Sequence and mapping of the aroA gene of Staphylococcus aureus 8325-4.

Authors:  C O'Connell; P A Pattee; T J Foster
Journal:  J Gen Microbiol       Date:  1993-07

10.  The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion.

Authors:  Christoph M Ernst; Petra Staubitz; Nagendra N Mishra; Soo-Jin Yang; Gabriele Hornig; Hubert Kalbacher; Arnold S Bayer; Dirk Kraus; Andreas Peschel
Journal:  PLoS Pathog       Date:  2009-11-13       Impact factor: 6.823

View more
  59 in total

Review 1.  The inhibition of type I bacterial signal peptidase: Biological consequences and therapeutic potential.

Authors:  Arryn Craney; Floyd E Romesberg
Journal:  Bioorg Med Chem Lett       Date:  2015-07-26       Impact factor: 2.823

2.  Impact of sarA and Phenol-Soluble Modulins on the Pathogenesis of Osteomyelitis in Diverse Clinical Isolates of Staphylococcus aureus.

Authors:  Allister J Loughran; Dana Gaddy; Karen E Beenken; Daniel G Meeker; Roy Morello; Haibo Zhao; Stephanie D Byrum; Alan J Tackett; James E Cassat; Mark S Smeltzer
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

3.  Reconstitution of Staphylococcus aureus Lipoteichoic Acid Synthase Activity Identifies Congo Red as a Selective Inhibitor.

Authors:  Christopher R Vickery; B McKay Wood; Heidi G Morris; Richard Losick; Suzanne Walker
Journal:  J Am Chem Soc       Date:  2018-01-09       Impact factor: 15.419

4.  Staphylococcus aureus hyaluronidase is a CodY-regulated virulence factor.

Authors:  Carolyn B Ibberson; Crystal L Jones; Shweta Singh; Matthew C Wise; Mark E Hart; Daniel V Zurawski; Alexander R Horswill
Journal:  Infect Immun       Date:  2014-07-28       Impact factor: 3.441

5.  Phosphatidylinositol-specific phospholipase C contributes to survival of Staphylococcus aureus USA300 in human blood and neutrophils.

Authors:  Mark J White; Jeffrey M Boyd; Alexander R Horswill; William M Nauseef
Journal:  Infect Immun       Date:  2014-01-22       Impact factor: 3.441

6.  Protein A is released into the Staphylococcus aureus culture supernatant with an unprocessed sorting signal.

Authors:  Dara P O'Halloran; Kieran Wynne; Joan A Geoghegan
Journal:  Infect Immun       Date:  2015-02-02       Impact factor: 3.441

7.  Type I signal peptidase and protein secretion in Staphylococcus aureus.

Authors:  Mark A Schallenberger; Sherry Niessen; Changxia Shao; Bruce J Fowler; Floyd E Romesberg
Journal:  J Bacteriol       Date:  2012-03-23       Impact factor: 3.490

8.  A partial reconstitution implicates DltD in catalyzing lipoteichoic acid d-alanylation.

Authors:  B McKay Wood; John P Santa Maria; Leigh M Matano; Christopher R Vickery; Suzanne Walker
Journal:  J Biol Chem       Date:  2018-09-20       Impact factor: 5.157

9.  Impact of the functional status of saeRS on in vivo phenotypes of Staphylococcus aureus sarA mutants.

Authors:  Karen E Beenken; Lara N Mrak; Agnieszka K Zielinska; Danielle N Atwood; Allister J Loughran; Linda M Griffin; K Alice Matthews; Allison M Anthony; Horace J Spencer; Robert A Skinner; Ginell R Post; Chia Y Lee; Mark S Smeltzer
Journal:  Mol Microbiol       Date:  2014-05-12       Impact factor: 3.501

10.  sarA-mediated repression of protease production plays a key role in the pathogenesis of Staphylococcus aureus USA300 isolates.

Authors:  Agnieszka K Zielinska; Karen E Beenken; Lara N Mrak; Horace J Spencer; Ginell R Post; Robert A Skinner; Alan J Tackett; Alexander R Horswill; Mark S Smeltzer
Journal:  Mol Microbiol       Date:  2012-10-17       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.